A pathologic role for GSK3β is supported by observations that inhibition of its activity reduced the survival and proliferation of different cancer cell types, predisposing them to apoptosis both in vitro and in tumor xenografts [73-76]. This evidence concerns the gene GSK3B and neoplasm.